Wolverine Trading, LLC Geron Corp Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Geron Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 14,819 shares of GERN stock, worth $59,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,819

Holding current value

$59,127

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $61,795 - $73,946	14,819 New	14,819 $67,000
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $19,589 - $38,507	11,194 New	11,194 $36,000
Q2 2023 Aug 23, 2023	BUY	$1.97 - $3.69 $1,266 - $2,372	643 Added 5.74%	11,839 $38,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $23,959 - $38,066	11,196 New	11,196 $24,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $54,752 - $96,390	32,786 New	32,786 $76,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $1,784 - $2,516	-1,463 Reduced 7.18%	18,903 $24,000
Q3 2021 Nov 12, 2021	BUY	$1.2 - $1.5 $6,961 - $8,701	5,801 Added 39.83%	20,366 $28,000
Q2 2021 Aug 06, 2021	SELL	$1.25 - $1.83 $15,653 - $22,917	-12,523 Reduced 46.23%	14,565 $20,000
Q1 2021 May 14, 2021	SELL	$1.52 - $2.1 $4,202 - $5,806	-2,765 Reduced 9.26%	27,088 $41,000
Q4 2020 Feb 12, 2021	BUY	$1.55 - $2.05 $6,895 - $9,120	4,449 Added 17.51%	29,853 $47,000
Q3 2020 Nov 13, 2020	SELL	$1.59 - $2.19 $30,335 - $41,783	-19,079 Reduced 42.89%	25,404 $45,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $15,993 - $33,205	15,232 Added 52.07%	44,483 $93,000
Q1 2020 May 11, 2020	BUY	$0.89 - $1.49 $6,420 - $10,748	7,214 Added 32.74%	29,251 $34,000
Q4 2019 Feb 12, 2020	BUY	$1.27 - $1.54 $5,709 - $6,923	4,496 Added 25.63%	22,037 $30,000
Q3 2019 Nov 14, 2019	BUY	$1.15 - $1.59 $2,331 - $3,222	2,027 Added 13.07%	17,541 $24,000
Q2 2019 Aug 20, 2019	SELL	$1.37 - $2.02 $59,853 - $88,251	-43,689 Reduced 73.8%	15,514 $22,000
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $9,077 - $16,448	8,988 Added 17.9%	59,203 $98,000
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $32,232 - $60,846	32,890 Added 189.84%	50,215 $51,000
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $9,048 - $32,799	5,141 Added 42.19%	17,325 $30,000
Q4 2017 Feb 14, 2018	SELL	$1.8 - $2.32 $32,410 - $41,773	-18,006 Reduced 59.64%	12,184 $22,000
Q3 2017 Nov 15, 2017	BUY	$1.99 - $2.65 $60,078 - $80,003	30,190	30,190 $66,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account